Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| NTRA | +65.40% | −6.42% | −5.13% | −7.66% | +41.51% | +82.81% | +90.48% | +834.45% | +232.07% | +250.79% |
| ES-GENOME | +62.79% | +0.74% | +3.41% | −8.31% | +27.43% | +59.28% | +52.50% | +72.28% | −45.83% | −47.83% |
| SCBGENOME(E) | +65.69% | −0.31% | +2.03% | −8.42% | +25.47% | +56.79% | +56.22% | +88.39% | −44.34% | −46.67% |
| TGHDIGI | +7.09% | +2.27% | +6.72% | +6.41% | +12.70% | +18.68% | +3.90% | +30.40% | −42.91% | −41.36% |
| UOBSHC | +7.46% | +2.10% | +4.97% | +8.65% | +7.78% | +13.73% | +15.46% | +17.79% | −8.60% | −8.25% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes NTRA: money market or bond funds, or no holdings data yet
| ES-GENOME | SCBGENOME(E) | |
|---|---|---|
| Held by both | ||
 Twist Bioscience | 10.83% | 10.03% |
 10x Genomics | 10.50% | 8.02% |
 Tempus AI Inc Class A common… | 9.36% | 7.15% |
 CRISPR Therapeutics | 5.49% | 4.20% |
 Absci | 5.30% | 4.05% |
| Personalis | 5.12% | 3.91% |
 Guardant Health | 4.83% | 3.69% |
 Natera | 4.75% | 3.63% |
 Illumina | 4.71% | 3.60% |
 CareDx | 4.55% | 3.48% |
30 Dec 2025 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| SCBGENOME(E) | +65.69% | 42.55% | 1.54 |
| ES-GENOME | +62.79% | 42.39% | 1.48 |
| NTRA | +65.40% | 52.61% | 1.24 |
| UOBSHC | +7.46% | 15.41% | 0.48 |
| TGHDIGI | +7.09% | 20.85% | 0.34 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | NTRA | ES-GENOME | SCBGENOME(E) | TGHDIGI | UOBSHC |
|---|---|---|---|---|---|
Fund details | |||||
| Fund size | N/A | 225 million | 46.19 million | 778 million | 1,258 million |
| Inception date | N/A | 23 Mar 2021 | 20 Aug 2021 | 1 Mar 2019 | 9 Sep 2014 |
| Master fund | N/A | กองทุนที่ลงทุนหลายกอง (ARK Genomic Revolution UCITS, ARK Genomic Revolution, iShares Genomics Immunology and Healthcare) | กองทุน ARK Genomic Revolution ETF | กองทุน UBS (Lux) Digital Health Equity | United Global Healthcare Fund |
| Dividend policy | N/A | Does not pay | Does not pay | Does not pay | Does not pay |
Risk and currency hedging | |||||
| Risk level | N/A | 7 | 7 | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 79.06% | 57.68% | 91.05% | 97.39% |
Minimum purchase and redemption | |||||
| First purchase | N/A | 1 THB | 1 THB | 1,000 THB | 0.01 THB |
| Subsequent purchase | N/A | 1 THB | 1 THB | 1,000 THB | 0.01 THB |
| Redemption (amount) | N/A | 1 THB | 1 THB | No minimum | 0.01 THB |
| Redemption (units) | N/A | 1 units | No minimum | No minimum | No minimum |
| Balance (amount) | N/A | No minimum | 1 THB | No minimum | No minimum |
| Balance (units) | N/A | No minimum | No minimum | 100 units | No minimum |
Order cut-off and redemption payment | |||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 15:30 | 15:30 | 14:00 |
| Redemption paid | N/A | T+4 | T+4 | T+5 | T+5 |
